Loading…

Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy

Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tole...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2021-07, Vol.8
Main Authors: Večerić-Haler, Željka, Kojc, Nika, Sever, Matjaž, Zver, Samo, Švajger, Urban, Poženel, Primož, Hartman, Katrina, Urdih, Tereza, Mlinšek, Gregor, Oblak, Manca, Aleš Rigler, Andreja, Ihan, Alojz, Buturović Ponikvar, Jadranka, Halloran, Philip P., Arnol, Miha
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mesenchymal stem cells (MSCs) have attracted great interest in the field of kidney transplantation due to their immunomodulatory and reparative properties. In registered clinical trials, MSCs have been used before, at the time of, or early after transplantation and have been reported to be well-tolerated with no serious safety concerns. No results are available on the use of MSCs in the late post-transplant period. Here, we present a case report of a severe systemic complication mimicking capillary leak syndrome with ultimate kidney transplant failure after autologous transplantation of MSCs used as rescue treatment of late antibody-mediated kidney allograft rejection.
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2021.708744